BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 16796416)

  • 1. Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology.
    Alberti C
    G Chir; 2015; 36(4):187-91. PubMed ID: 26712075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retroperitoneal fibrosis associated with chronic use of ergotamine: report of one case].
    Vega J; Goecke H; Santamarina M
    Rev Med Chil; 2011 Apr; 139(4):489-94. PubMed ID: 21879189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergotamine as a possible cause of retroperitoneal fibrosis.
    Lepage-Savary D; Vallières A
    Clin Pharm; 1982; 1(2):179-80. PubMed ID: 7185517
    [No Abstract]   [Full Text] [Related]  

  • 4. Retroperitoneal fibrosis after long-term daily use of ergotamine.
    Damstrup L; Jensen TT
    Int Urol Nephrol; 1986; 18(3):299-301. PubMed ID: 3771129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid artery dissection in ergotamine abuse.
    Akova-Oztürk E; Husstedt IW; Ringelstein EB; Evers S
    Headache; 2004 Oct; 44(9):930-2. PubMed ID: 15447707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular fibrillation secondary to ergotamine in a healthy young woman.
    Velez Roa S; Preumont N; Mols P; Stoupel E; Renard M
    Acta Cardiol; 1999 Oct; 54(5):283-6. PubMed ID: 10596308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retroperitoneal fibrosis secondary to ergotamine use].
    Martín Azcárate MD; Hernández Muro G; Isusquiza I
    An Med Interna; 2006 Apr; 23(4):193-4. PubMed ID: 16796416
    [No Abstract]   [Full Text] [Related]  

  • 8. Ergotamine, dihydroergotamine: current uses and problems.
    Tfelt-Hansen P
    Curr Med Res Opin; 2001; 17 Suppl 1():s30-4. PubMed ID: 12463275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroperitoneal fibrosis due to ergotamine. Apropos a case].
    Moltó Ripoll F; Merenciano Cortina FJ; Herraiz Romero I; Vilas Ferrol I; Fernández-Moscoso López-Duran A; Muñoz Nuñez C; Martínez Salinas P
    Arch Esp Urol; 1995 May; 48(4):400-3. PubMed ID: 7598553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medication-overuse headache].
    Rabe K; Katsarava Z
    MMW Fortschr Med; 2006 Aug; 148(35-36):37-8. PubMed ID: 16995362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergotamine in the acute treatment of migraine: a review and European consensus.
    Tfelt-Hansen P; Saxena PR; Dahlöf C; Pascual J; Láinez M; Henry P; Diener H; Schoenen J; Ferrari MD; Goadsby PJ
    Brain; 2000 Jan; 123 ( Pt 1)():9-18. PubMed ID: 10611116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.